🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT05596344
Recruiting Observational

Long-term Follow-up of Anxiety and Depression in Patients With Malignant Tumors

NCT05596344 · tracked via the Priya Life Science China tracker
Sponsor
Henan Cancer Hospital
Phase
Observational
Started
2023-05-20
Last updated
2023-11-13

Condition(s) studied

Malignant TumorAnxietyDepression

Investigational drug(s) / intervention(s)

Hospital Anxiety and Depression Scale

Hospital Anxiety and Depression Scale: The basic information, anxiety and depression, treatment and prognosis of these patients were collected.

Study summary

This study was a single-center prospective, real-world observational study with plans to enroll all eligible patients. The basic information, anxiety and depression, treatment and prognosis of these patients were collected.

Eligibility

Sex
ALL
Min age
Max age
Healthy volunteers
No
Inclusion Criteria: 1. Men and women of all ages are welcome. 2. Pathological diagnosis of malignant tumor in our hospital. 3. Received at least one hospitalization at this hospital. 4. The expected survival time is greater than 1 year. Exclusion Criteria: 1.There was no pathological report of malignancy.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Department of Bone and Soft Tissue ,Henan Cancer Hospital Zhengzhou Henan Recruiting

More Henan Cancer Hospital trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05596344 on ClinicalTrials.gov ↗ ← All trials in China